Cataract-deafness-hypogonadism syndrome

Cataract-deafness-hypogonadism syndrome (also known as CDH syndrome) is an extremely rare genetic disorder characterized by the triad of bilateral cataracts, sensorineural hearing loss (deafness), and hypogonadism. The condition affects multiple body systems, including the eyes, the auditory system, and the reproductive/endocrine system. Cataracts typically present early in life and can lead to significant visual impairment if untreated. Sensorineural deafness ranges from moderate to severe and affects communication and development. Hypogonadism, which refers to reduced function of the gonads (testes or ovaries), can result in delayed or incomplete puberty, infertility, and other hormonal deficiencies. Additional features that have been reported in some patients include short stature and mild intellectual disability, though the clinical spectrum may vary among affected individuals. The syndrome was first described in a small number of families, and very few cases have been reported in the medical literature, making it one of the rarest multisystem genetic conditions. The exact genetic basis of this syndrome remains incompletely characterized. There is no specific cure for cataract-deafness-hypogonadism syndrome. Treatment is symptomatic and supportive, involving surgical removal of cataracts to restore vision, hearing aids or cochlear implants for hearing loss, and hormone replacement therapy to address hypogonadism and promote normal pubertal development and reproductive function. Regular follow-up with ophthalmology, audiology, and endocrinology specialists is recommended for comprehensive management.

Common questions about Cataract-deafness-hypogonadism syndrome